The glucokinase gene is 15.5-kilobases long, appears to be present as a single copy, and contains 10 exons that range in size from 96 to 977 base pairs. The transcription start site was located 127 nucleotides upstream from the translation initiation codon. The 5' flanking DNA contains several regions similar to dermed promoter elements. These include a probable "TATA box," an Spl binding site, and several elements related to liver-specific gene expression. In addition, we determined that transcription of the glucokinase gene increased at least 20-fold when diabetic rats were treated with insulin for 2 hr.
Glucokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) plays a key role in the regulation of glucose homeostasis by catalyzing the first step in glycolysis (1) . Expression of the enzyme is limited to hepatocytes and pancreatic ,B cells (2, 3) , and it is regulated differently in these two tissues. The hepatic enzyme is induced by insulin and repressed by cAMP (4) whereas in the p cell glucokinase activity is increased by glucose (5) . The glucokinase gene is, therefore, of interest both because of its tissue-specific expression and because of the several regulatory processes that can be analyzed. Before the cis-acting DNA elements responsible for the tissuespecific expression and hormonal regulation of this enzyme can be identified and studied, the structure of the glucokinase gene, the transcription unit in each tissue, and the sequence of its 5' flanking DNA must be determined.
Glucokinase is thought to be a member of a family of hexokinases that have a common evolutionary origin (6) . This concept was based on indirect evidence because none of the complete structures of the mammalian hexokinases were available. We recently deduced the structure of rat liver glucokinase and found that it shares 33% and 53% amino acid sequence identity with yeast hexokinase and the carboxylterminal portion of rat brain hexokinase I, respectively (7) . We now have determined the structure of the glucokinase genet as an initial step toward answering how the various hexokinase isozymes are related to each other.
EXPERIMENTAL PROCEDURES General Techniques. Standard procedures were used for screening phage libraries, DNA labeling, restriction enzyme mapping, subcloning, isolation of genomic DNA, and Southern transfers (8) . RNA was isolated from the livers ofdiabetic rats by the method of Chirgwin et al. (9) . Genomic DNA fragments were subcloned into pEMBL (10) or Bluescript M13+ (Stratagene) plasmid vectors for restriction map analysis and DNA sequencing using the dideoxynucleotide method (11 Pipes (pH 7.0), 0.4 M NaCl, and 1 mM EDTA. The mixtures were heated at 75TC for 15 min and incubated at 500C overnight. After the hybridization, 300 p.l of a solution containing 300 mM NaCl, 3 mM ZnSO4, 60 mM sodium acetate (pH 4.5), and 200 units of S1 nuclease was added and the reaction mixture was incubated at 37°C for 1 hr. After phenol extraction and ethanol precipitation, the DNA was size-fractionated on a 5% polyacrylamide/7 M urea gel and an autoradiograph was obtained.
Transcription Run-On Analysis. Male Sprague-Dawley rats weighing 125-150 g (Harlan Animal Supply, Indianapolis) were made diabetic as described (12) . Rat liver nuclei were isolated by the method of Schibler et al. (13) , except that the suspension buffer was that of Sasaki et al. (14) . The elongation of nascent RNA transcripts was quantitated essentially as described by McKnight and Palmiter (15) and modified by Sasaki et al. (14) . The plasmid DNAs bound to the filters to measure transcription were, for glucokinase, pGK.Z1; for the glucokinase control, Bluescript M13+; for phosphoenolpyruvate carboxykinase (PEPCK), PC116 (16) BamHI, as indicated, size-fractionated on a 1.0% agarose gel, and transferred to a nylon membrane. The hybridization probe was a 389-bp BstEH-EcoRI 32P-labeled DNA fragment isolated from the GK1 cDNA (7) . Size markers were electrophoresed in an adjacent lane.
RESULTS
Southern Analysis of Genomic DNA. A Southern blot hybridization of rat genomic DNA was performed to determine whether there were multiple glucokinase genes or other closely related genes. A fragment of the liver glucokinase cDNA was used to probe EcoRI, BamHI, and HindIII restriction digests of rat genomic DNA. As shown in Fig. 1 , a single DNA species was seen for each restriction digest. This result suggests that the glucokinase gene is present in the rat genome as a single copy.
Screening for the Rat Glucokinase Gene. A glucokinase genomic DNA fragment, AGK2, was identified by screening a rat genomic DNA library in EMBL3 with the partial-length glucokinase cDNA GK1 (7). The restriction map of the insert in AGK2 (Fig. 2) predicted EcoRI, BamHI, and HindIlI fragments of the lengths seen in the genomic Southern blot experiment ( Fig. 1 ), indicating that AGK2 contained some part of the glucokinase gene. A DNA fragment from near the 5' end of AGK2 was isolated and used to probe additional recombinant bacteriophage from a different, unamplified rat genomic library to identify DNA segments that would overlap AGK2 but extend farther in the 5' direction. Two additional clones (AGK5 and AGK9) that overlapped AGK2 and extended further in the 5' direction were isolated (Fig. 2) . AGK5 extended 13.5 kilobases (kb) farther than AGK9 so it was subjected to additional analysis. Thus genomic DNA was found to contain 10 exons and the entire hepatic transcription unit of the glucokinase gene.
Intron-Exon Organization of the Gene. The location of individual exons within the glucokinase gene was determined by a combination of Southern blot analysis and DNA sequencing (Fig. 3) . The intron-exon junctions were determined by sequencing the genomic DNA with exon-specific primers and comparing this sequence with the cDNA sequence. All of the exons of the glucokinase gene were sequenced (Fig. 3) and these data were compared to the cDNA sequence (7) . Three single-base differences between the cDNAs and genomic DNAs were identified §; however, none changed the predicted amino acid sequence of the protein (7). Splice sites, located at points of cDNA and genomic DNA homology divergence, were determined by obtaining the best fit to the splice consensus sequence (17) .
The putative intron-exon splice site sequences are shown in Table 1 . The exons ranged in size from 96 bp to 977 bp.
Identification of the Transcription Initiation Sites. The S1 nuclease protection assay was used to identify the transcription initiation site(s) of the glucokinase gene. After hybridization of the S1 probe to poly(A)+ RNA isolated from the livers of diabetic and insulin-treated diabetic rats, the hybridization products were treated with S1 nuclease, and then the protected DNA fragments were size-fractionated and visualized by autoradiography. A portion of the autoradiograph obtained is shown in Fig. 4A . Lanes A-D show DNA size markers from a dideoxynucleotide sequencing reaction. S1 nuclease-resistant fragments were obtained when RNA from the insulin-treated diabetic rats was used (lane E) but not when the RNA was isolated from the untreated diabetic rats (lane F). The protected DNA fragments varied in size from 83 to 89 bases but the strongest bands were 87-89 bases long, centered around an adenine.
A primer-extension assay was also used to locate the transcription initiation site. A portion of the autoradiograph obtained from this experiment is shown in Fig. 4B . Lane E shows the DNA products of a primer-extension reaction using poly(A)+ RNA from the livers of insulin-treated diabetic rats and lane F shows the products from poly(A)+ RNA from the livers of diabetic rats. The following results correspond with the S1 nuclease protection experiment: (i) Products derived from glucokinase mRNA were seen only in lane §The sites at which the glucokinase cDNA and genomic DNA sequences differ are described in the sequence data submitted to GenBank. obtain it is shown in Fig. 3 . As can be seen by examining this sequence, the cap site is located 127 bases upstream from the ATG initiation codon. Eleven additional nucleotides not present in the GK.Z2 cDNA (7) were placed in the first exon of the gene by this analysis. Regulation of Glucokinase Gene Transcription by Insulin. As an initial step in the effort to understand how insulin exerts positive and negative effects on transcription in the same cell, we quantitated transcription of the PEPCK and glucokinase genes in the same aliquots of nuclei isolated from the livers of diabetic rats. Transcription of the glucokinase gene was at the limit of detection in the absence of insulin (Fig. 6 ) but increased to 15 ppm at 0.5 hr, to 309 ppm at 1 hr, and to 619 ppm at 2 hr after insulin treatment. Transcription of the PEPCK gene decreased from 6954 ppm in the untreated diabetic animal to 1666 ppm at 0.5 hr, to 754 ppm at 1 hr, and to 1027 ppm after 2 hr of insulin treatment. A somewhat different transcription run-on experiment was performed to validate the magnitude of the induction of glucokinase gene transcription by insulin. Nuclei were isolated from untreated diabetic rats and from diabetic rats treated with insulin for 2 hr. In this experiment the hybridization filters were exposed to film for 2 weeks and the induction was quantitated by densitometry. Transcription of the glucokinase gene increased at least 20-fold (data not shown). E, which contains RNA isolated from the insulin-treated rats.
(it) Bands of 85-88 bases long were seen. (iii) Transcription initiation was localized over a range of 4 bases. (iv) The strongest band, 88 nucleotides long, corresponds to initiation at an adenine on the glucokinase gene. Since this base is near the center of the size range seen for the S1 nuclease protection experiment (compare Fig. 4 A and B) , it was designated as position + 1 for numbering the nucleotides in the glucokinase gene.
Glucokinase Promoter Sequence. The sequence of the DNA on both sides of the transcription initiation site was determined. A Bgl II site located 1448 bp upstream of adenine + 1 was the limit for sequence determination in the 5' direction. This sequence is shown in Fig. 5 (17) . The TATA box is generally considered to be important for the precise positioning of transcription initiation (17 (18, 19) .
The 5' flanking DNA sequence ofthe glucokinase gene was searched for the presence of elements found in several liver-specific genes (20, 21) . Hepatocyte nuclear factor I binds to the DNA sequence ATTAAC in a region of the a1-antitrypsin gene demonstrated to be essential for tissuespecific expression (20) . Elements containing the same AT-TAAC core sequence are located in the promoters of the aand P-fibrinogen genes and appear to bind the same protein (20) . The sequence ATTAAC is located in the promoter region of the glucokinase gene (positions -171 to -166). Liver factor Al, another protein that may be important for liver-specific gene expression, binds to the DNA sequence TG(G/A)(A/C)CC (21) . This motif is present in the regulatory region of the human a1-antitrypsin, apolipoprotein Al, and haptoglobin-related genes (21) . Several copies of this DNA sequence are located in the 5' flanking region of the glucokinase gene. Single copies of the sequence lie at positions -795 to -790 and -684 to -679, while three tandem repeats of the sequence, TGGCCC, occur between positions -70 and -53.
Insulin Regulates Glucokinase mRNA Synthesis in the Liver. Our results indicate that the increase of glucokinase mRNA in response to insulin treatment of diabetic rats occurs primarily at a transcriptional level. The magnitude and kinetics of the increase, at least a 20-fold change within 2 hr, correspond well with data reported (22) . The increase in transcription is rapid; it occurs within 1 hr of injection of the animal with insulin. The rapidity of insulin's action on the transcription of the glucokinase gene suggests that a direct effect is involved, as is the case in the suppression of transcription of the PEPCK gene by insulin (23) . Transcription of the PEPCK gene was inhibited while the glucokinase gene was stimulated by insulin treatment, but the kinetics of the changes in the transcription rates for the two genes were remarkably similar. In the diabetic animal the PEPCK gene is maximally stimulated (almost 7000 ppm) while the glucokinase gene is virtually inactive. Thus, these promoters have dramatically different basal activities in absence of insulin, and in the presence of insulin the transcription of one gene is stimulated while that of the other is inhibited.
Insulin response elements (IREs) probably reside upstream of genes regulated by insulin. In addition to PEPCK (23) and glucokinase, transcription of the growth hormone (24), glyceraldehyde-3-phosphate dehydrogenase (25) , gene 33 (26, 27) , c-fos (28) , and amylase (29) genes is regulated by insulin. A consensus IRE has not been identified; however, when 5' flanking DNA from some of these genes is linked to reporter genes and expressed either in responsive cell lines or in transgenic mice, the expected effect of insulin is conferred (30) . It will be interesting to compare the IREs from a gene stimulated by insulin (e.g., glucokinase) with one inhibited by insulin (e.g., PEPCK) to determine whether similar or different IREs are involved and whether similar or different transcription factors are involved.
Concluding Statement. The availability of the glucokinase gene, including significant 5' flanking DNA, makes possible the construction of fusion genes that can be used to identify the elements that confer tissue-specific and hormoneregulated expression. The characterization of this gene also represents an important step toward elucidating the evolution of the hexokinase enzyme family.
Note Added in Proof. Two recent papers present evidence in favor of the hypothesis that the mammalian hexokinases of -100 kDa evolved from an -50-kDa ancestral molecule through a process of gene duplication and tandem ligation (31, 32) .
